Literature DB >> 29563393

Accelerated Atherogenicity in Tangier Disease.

Jun Muratsu1, Masahiro Koseki2,3, Daisaku Masuda2, Yuji Yasuga1, Satoki Tomoyama1, Keiji Ataka4, Yoshiki Yagi5, Atsushi Nakagawa5, Hidehumi Hamada5, Shigeki Fujita6, Hiroaki Hattori7, Tohru Ohama2, Makoto Nishida2,3, Hisatoyo Hiraoka1, Yuji Matsuzawa1, Shizuya Yamashita2,8.   

Abstract

We report a case of Tangier disease with Leriche syndrome and bleeding tendency. In this male patient, nasal hemorrhage had been observed frequently throughout childhood. At 46 years old, he experienced effort angina, and coronary angiography demonstrated 75% stenosis in the right coronary artery. Orange-colored tonsils, mild hepatosplenomegaly and very low levels of serum high-density lipoprotein cholesterol (HDL-C) were observed, and the patient was diagnosed with Tangier disease. At 52 years old, effort angina recurred. Coronary angiography revealed 75% stenosis of the left main trunk, left anterior descending, and right coronary arteries. Stenosis of the brachiocephalic and right common iliac arteries was also recorded. Stents were implanted, and coronary artery bypass surgery was performed. At 53 years old, 15 months after surgery, the patient reported intermittent claudication, coldness of feet, and impotence. Aortic angiography showed progression of the stenosis at the bifurcation of the common iliac artery. The patient was diagnosed with Leriche syndrome, and aorta-left external iliac artery graft bypass surgery was performed. After surgery, oozing from subcutaneous tissue and leaking from the anastomotic region were observed. Additional analysis revealed two single-nucleotide polymorphisms (V825I and N935T) in the ATP-binding cassette transporter A1 (ABCA1) gene, and accumulation of small dense low-density lipoprotein together with low levels of HDL-C. In Tangier disease, HDL-C is markedly decreased because of ABCA1 deficiency. However, this is the first reported case to exhibit extensive atherosclerosis and bleeding tendency. This patient had atypical extensive and multiple atherosclerotic lesions, accompanied by Leriche syndrome and uncontrollable bleeding.

Entities:  

Keywords:  ABCA1; Atherosclerosis; HDL; Leriche syndrome; Tangier disease

Mesh:

Year:  2018        PMID: 29563393      PMCID: PMC6193190          DOI: 10.5551/jat.43257

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  17 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Tangier disease with continuous massive and longitudinal diffuse calcification in the coronary arteries : demonstration by the sagittal images of intravascular ultrasonography.

Authors:  R Komuro; S Yamashita; S Sumitsuji; K Hirano; T Maruyama; M Nishida; F Matsuura; A Matsuyama; T Sugimoto; N Ouchi; N Sakai; T Nakamura; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

4.  ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.

Authors:  N Wang; D L Silver; C Thiele; A R Tall
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

5.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.

Authors:  S Rust; M Rosier; H Funke; J Real; Z Amoura; J C Piette; J F Deleuze; H B Brewer; N Duverger; P Denèfle; G Assmann
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

6.  ATP-binding cassette transporter 1 C69T and V825I polymorphisms in the development of atherosclerosis: a meta-analysis of 18,320 subjects.

Authors:  Yan-Wei Yin; Qi Wang; Qian-Qian Sun; Ai-Min Hu; Hong-Li Liu
Journal:  Thromb Res       Date:  2014-11-04       Impact factor: 3.944

7.  Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux.

Authors:  K Hirano; F Matsuura; K Tsukamoto; Z Zhang; A Matsuyama; K Takaishi; R Komuro; T Suehiro; S Yamashita; Y Takai; Y Matsuzawa
Journal:  FEBS Lett       Date:  2000-11-10       Impact factor: 4.124

8.  Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages.

Authors:  Masahiro Koseki; Ken-Ichi Hirano; Daisaku Masuda; Chiaki Ikegami; Masaki Tanaka; Akemi Ota; Jose C Sandoval; Yumiko Nakagawa-Toyama; Satoshi B Sato; Toshihide Kobayashi; Yukiko Shimada; Yoshiko Ohno-Iwashita; Fumihiko Matsuura; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Lipid Res       Date:  2006-11-01       Impact factor: 5.922

Review 9.  Homozygous Tangier disease and cardiovascular disease.

Authors:  C Serfaty-Lacrosniere; F Civeira; A Lanzberg; P Isaia; J Berg; E D Janus; M P Smith; P H Pritchard; J Frohlich; R S Lees
Journal:  Atherosclerosis       Date:  1994-05       Impact factor: 5.162

10.  Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.

Authors:  Masahiro Koseki; Akifumi Matsuyama; Kazuhiro Nakatani; Miwako Inagaki; Hajime Nakaoka; Ryota Kawase; Miyako Yuasa-Kawase; Kazumi Tsubakio-Yamamoto; Daisaku Masuda; Jose C Sandoval; Tohru Ohama; Yumiko Nakagawa-Toyama; Fumihiko Matsuura; Makoto Nishida; Masato Ishigami; Ken-ichi Hirano; Naoki Sakane; Yoshitaka Kumon; Tadashi Suehiro; Tadashi Nakamura; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2009-06-25       Impact factor: 4.928

View more
  5 in total

Review 1.  [Inborn errors of high-density lipoprotein metabolism].

Authors:  Arnold von Eckardstein
Journal:  Internist (Berl)       Date:  2019-12       Impact factor: 0.743

2.  Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis.

Authors:  Mei Zhou; R Marc Learned; Stephen J Rossi; Hui Tian; Alex M DePaoli; Lei Ling
Journal:  J Lipid Res       Date:  2019-01-24       Impact factor: 5.922

Review 3.  The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.

Authors:  Leonor Jacobo-Albavera; Mayra Domínguez-Pérez; Diana Jhoseline Medina-Leyte; Antonia González-Garrido; Teresa Villarreal-Molina
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

Review 4.  Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.

Authors:  Shizuya Yamashita; Daisaku Masuda; Yuji Matsuzawa
Journal:  Curr Atheroscler Rep       Date:  2020-01-23       Impact factor: 5.113

Review 5.  Current Diagnosis and Management of Tangier Disease.

Authors:  Masahiro Koseki; Shizuya Yamashita; Masatsune Ogura; Yasushi Ishigaki; Koh Ono; Kazuhisa Tsukamoto; Mika Hori; Kota Matsuki; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-14       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.